1.He’nan Key Laboratory of Medical Tissue Regeneration; 2.Department of Cardiology，the Second Affiliated Hospital of Xinxiang Medical University，He’nan Xinxiang 453003，China
YU XiaLI Qiong REN Ming-fen NIU Yan-fei GAN Li GUO Zhi-kun*. Expression difference of surface markers between adipose derived mesenchymal stem cells and bone marrow mesenchymal stem cells of the mouse[J]. AAS, 2016, (2): 203-208.
［1］Tzaribachev N，Vaeqler M，schaefer J，et al.Mesenchymal stromal cells：a nomal treatment option for steroid-induced avascular osteonecrosis［J］.Isr Med Assoc J，2008，10(3)：232-234.
［2］Nauta AJ，Fibbe WE. Immunomodulatory properties of mesenchymal stromal cells［J］ Blood，2007，110（10）：3499-3506.
［3］B?nner F， Borg N，Jacoby C，et al.Ecto-5’-nucleotidase on immune cells protects from adverse cardiac remodeling［J］.Circ Res，2013，113(3)：301-312.
［4］Bensidhoum M，Chapel A，Francois S，et al.Homing of in vitro expanded Stro-1-or Stro-1+ mesenchymal stem cells into the NOD/SCID mouse and their role in supporting human CD34 cell engraftment［J］ .Blood, 2004，103（9）：3313-3319.
［5］Pittenger MF，Mackay AM，Beck SC，et al.Multilineage potential of adult human mesenchymal stem cells［J］.Science，1999，284(5411)：143-147.
［6］Zuk PA，Zhu M，Morizono H，et al.Muhilineagecells from human adipose tissue impliczaionsfor ceils based therapies［J］.Tissue Eng，2001，7(7)：211-228.
［7］Calloni R， Cordero EA， Henriques JA，et al.Reviewing and updating the major molecular markers for stem cells［J］.Stem Cells Dev，2013，22(9)：1455-1476.
［8］Patricia A，Zuk M，Hiroshi M，et al.Muhilineage cells from human adipose tissue：implication for cellbased therapies［J］.Tissue Eng，2001，(2)：211-228.
［9］De Ugarte DA，Morizono K，Elbarbary A，et al.Comparision of muItilineage cells from human adipose tissue and bone marrow［J］.Cells Tissues Organs，2003，174(3)：101-109.
［10］Gaebel R， Furlani D，Sorg H，et al.Cell origin of human mesenchymal stem cells determines a different healing performance in cardiac regeneration［J］.PLoS One，2011(6)：1-14.
［11］Zannettino AC，Paton S，Itescu S，et al.Comparative assessment of the osteoconductive properties of different biomaterialsseeded with human or ovine mesenchymal stem/stromal cells ［J］.Tissue Eng Part A，2010，16(12)：3579-3587.
［12］Meirelles Lda S， Nardi NB.Methodology，biology and clinical applications of mesenchymal stem cells ［J］.Front Biosci，2009，14(1)：4281-4298.
［13］De Ugarte DA，Alfonso Z，Zuk PA，et al.Differential expression of stem cell mobilization associated molecules on multilineage cells from adipose tissue and bone marrow［J］.Immunol Lett，2003，89(23)：267-270.
［14］Geng S，Guo Y，Wang Q.Cancer stem-like cells enriched with CD29 and CD44 markers exhibit molecular characteristics with epithelial-mesenchymal transition in squamous cell carcinoma［J］.Arch Dermatol Res，2013，305: 35-47.
［15］Li Q，Qi LJ， Guo ZK， et al.CD73 + adipose-derived mesenchymal stem cells possess higher potential to differentiate into cardiomyocytes in vitro［J］.J Mol Histol，2013，44(4)：411-422.
［16］B?nner F，Borg N，Jacoby C，et al.Ecto-5’-nucleotidase on immune cells protects from adverse cardiac remodeling［J］.Circ Res，2013，113(3)：301-312.
［17］Ode A，Schoon J，Kurtz A，et al.CD73/5’-ecto-nucleotidase acts as a regulatory factor in osteo-/chondrogenic differentiation of mechanicaly stimulated mesenchymal stromal cells ［J］.Eur Cell Mater，2013，（25）：37-47.
［18］Herbert Zimmerman，AK Neurochemie， Zoologisches Institut der JW, et al.5’-Nucleotidase: molecular structure and functional aspects［J］.Biochem J，1992，285(Pt2)：345-365.
［19］Tessier L，Bienzle D，Williams LB，et al. Phenotypic and immunomodulatory properties of equine cord blood-derived mesenchymal stromal cells［J］.PLoS One，2015，10(4):1-19.
